PCOS Is Now PMOS: Why the Name Changed—and Why “Ovarian Cysts” Were Never the Whole Story

If you've ever been told you have "cysts" on your ovaries and immediately wondered whether you have PCOS, I want to clear something up:

Having ovarian cysts does not mean you have PCOS.

And you can absolutely have the condition we've historically called PCOS without having ovarian “cysts.”

That confusion isn't just a social-media misconception. It's one of the problems experts have been trying to address for years.

And now, they're changing the name.

In May 2026, polycystic ovary syndrome (PCOS) was officially renamed polyendocrine metabolic ovarian syndrome (PMOS) following a major international consensus process.

And as a biomedical engineer and women's health educator, I'm genuinely excited about this change.

Not because changing terminology magically changes healthcare overnight.

But because language shapes how we understand disease.

And for decades, the name PCOS hasn't accurately represented what's happening in the body.

Is PCOS really being renamed PMOS?

Yes. Polycystic ovary syndrome (PCOS) has been renamed polyendocrine metabolic ovarian syndrome (PMOS).

The change was announced in May 2026 following a global consensus process led by Monash University and international partners.

The process took 14 years and involved 56 patient and professional organizations, more than 22,000 survey responses, international workshops, healthcare professionals and people living with the condition.

The American Society for Reproductive Medicine has also endorsed the new terminology.

This isn't simply a proposed nickname.

PMOS is the new name for the condition previously known as PCOS.

That said, we're currently in a transition period. You'll continue seeing PCOS, PMOS, and sometimes PMOS/PCOS used together while healthcare systems, clinicians, researchers and patients adapt to the new terminology.

The updated International Guideline notes that the clinical recommendations themselves remain unchanged, with PMOS expected to become standard terminology in the next full guideline update in 2028.

What does PMOS stand for?

PMOS stands for:

Polyendocrine Metabolic Ovarian Syndrome.

And every part of that name is intentional.

Polyendocrine reflects the involvement of multiple interacting hormonal or endocrine systems.

Metabolic acknowledges the important metabolic features of the condition, including glucose regulation and insulin resistance in many affected individuals.

Ovarian recognizes that ovarian and reproductive function remain important components of the condition.

Syndrome reflects the fact that PMOS can present as a collection of different signs, symptoms and biological features rather than looking identical in everyone.

Compare that with:

Polycystic Ovary Syndrome.

One name immediately makes you think about cysts.

The other tells you we're dealing with a broader endocrine, metabolic and reproductive condition.

That distinction matters.

Why was the name PCOS considered inaccurate?

Here's the part I really want women to understand:

The “cysts” in PCOS were never actually the defining pathological cysts the name made them sound like.

What clinicians can see on ultrasound is more accurately described as a pattern of numerous small ovarian follicles.

Follicles are structures in the ovary containing developing eggs.

They are not the same thing as the ovarian cysts people commonly hear about in other gynecologic situations.

The updated international guideline specifically explains that the ovarian appearance associated with this condition reflects arrested follicular development—not abnormal cyst formation.

That means the old name created a biological misunderstanding right from the start.

Can you have PMOS without ovarian cysts?

Yes. You do not need ovarian “cysts” or polycystic ovarian morphology to be diagnosed with PMOS in adulthood if other diagnostic criteria are met.

This is one of the biggest misconceptions surrounding the condition.

Under current international evidence-based guidance, adult diagnosis generally involves meeting two of three features, after other relevant conditions have been excluded:

1. Ovulatory dysfunction, such as irregular or absent ovulation.

2. Clinical or biochemical hyperandrogenism, meaning signs or laboratory evidence of elevated androgen activity.

3. Polycystic ovarian morphology identified by ultrasound. In adults, anti-Müllerian hormone (AMH) can also be used as an alternative to ultrasound within the current diagnostic algorithm.

If someone already has irregular cycles/ovulatory dysfunction and hyperandrogenism, ovarian ultrasound or AMH isn't required to establish the diagnosis.

So no:

No cysts does not automatically mean no PMOS.

And seeing ovarian cysts does not automatically mean you have PMOS.

Why does changing the name actually matter?

You might be thinking:

Okay, but isn't this just semantics?

I don't think it is.

Imagine being told you have polycystic ovary syndrome.

Naturally, you might assume:

"My ovaries are covered in cysts."

Or:

"My doctor said I don't have cysts, so I can't have PCOS."

Or even:

"This is primarily an ovarian or fertility condition."

Those assumptions can fundamentally change how someone understands their diagnosis.

And according to the international group behind the name change, that narrow ovarian focus has contributed to confusion, delayed diagnosis, fragmented care and stigma.

The old name directed our attention toward the ovaries.

PMOS asks us to look at the whole person.

PMOS is more than a period or fertility condition

This may be the most important reason I like the new terminology.

For years, conversations about PCOS have overwhelmingly centered on:

• irregular periods

• ovarian cysts

• infertility

• getting pregnant

Those are important.

But they're not the entire condition.

PMOS can involve reproductive, endocrine, metabolic, dermatologic, cardiovascular, sleep and psychological health.

Depending on the individual, features can include:

• irregular or absent ovulation

• irregular menstrual cycles

• acne

• increased facial or body hair

• scalp hair thinning

• androgen excess

• insulin resistance

• impaired glucose regulation

• fertility challenges

• sleep apnea risk

• depression and anxiety

• metabolic and cardiovascular risk factors

Not every person with PMOS will experience every one of these.

That's why it's called a syndrome.

Does everyone with PMOS have insulin resistance?

No.

Insulin resistance is an important part of PMOS physiology for many people, but the condition is heterogeneous.

This is another reason I want us to be careful about oversimplifying PMOS just as we oversimplified PCOS.

Changing the name doesn't mean we should go from:

“It's all about ovarian cysts.”

to:

“It's all about insulin resistance.”

Neither is accurate.

PMOS involves complex interactions between endocrine, reproductive and metabolic systems, and those interactions can look different from person to person.

Can you have PMOS in a smaller body?

Absolutely.

PMOS occurs across body sizes.

One of the persistent problems in PCOS/PMOS care is the assumption that someone has to look a certain way to have the condition.

They don't.

Current international guidance specifically recognizes the harms of weight stigma in the care of people with PMOS.

Body size alone cannot tell us whether someone has the condition, whether they're ovulating regularly, what their androgen levels are doing, or what their metabolic health looks like.

What about adolescents?

Diagnosis during adolescence requires additional caution because features that may suggest PMOS in adults can also overlap with normal pubertal development.

Current international guidance requires both ovulatory dysfunction and hyperandrogenism for adolescent diagnosis after other causes have been considered.

Ultrasound and AMH are not recommended for diagnosing PMOS during adolescence because they lack adequate specificity during this stage of development.

That's another important example of why finding “polycystic-looking” ovaries isn't synonymous with having the syndrome.

Did the diagnostic criteria change when PCOS became PMOS?

No. The May 2026 terminology update did not change the existing evidence-based diagnostic or management recommendations.

That's an important distinction.

This is a change in how we name and conceptualize the condition—not evidence that everyone previously diagnosed with PCOS suddenly needs to be rediagnosed.

If you were diagnosed with PCOS, you haven't developed a new condition.

PMOS is the new name for the condition you already know.

Why did it take so long to rename PCOS?

The criticism isn't new.

The condition was named in the 1930s based largely on ovarian appearance.

As our understanding of the syndrome expanded, researchers and clinicians increasingly recognized that the name was biologically incomplete and potentially misleading.

The U.S. National Institutes of Health recommended considering a name change as far back as 2012, and the 2023 International Evidence-Based PCOS Guideline again stated that the name should be changed.

But changing the name of a condition used worldwide isn't simple.

The eventual consensus process included people with lived experience, clinicians, researchers, advocacy organizations and professional societies from around the world.

That's important to me.

Women weren't simply informed that experts had decided to rename their condition.

People living with the condition were central to the process.

Will doctors start calling it PMOS immediately?

Some already are.

Others will continue using PCOS during the transition.

The International Guideline has already been updated to use PMOS, formerly PCOS, and organizations including the American Society for Reproductive Medicine have endorsed the new terminology.

However, healthcare systems don't change terminology overnight.

Medical records, insurance coding, research databases, clinician education and patient resources all have to catch up.

A three-year implementation period is underway, with PMOS intended to become standard terminology in the 2028 International Guideline.

So if you see PCOS and PMOS being used interchangeably for a while, that doesn't mean one source is necessarily wrong.

We're watching a medical terminology change happen in real time.

Frequently Asked Questions

What is the new name for PCOS?

The new name for polycystic ovary syndrome (PCOS) is polyendocrine metabolic ovarian syndrome (PMOS). The change was announced internationally in May 2026.

Why was PCOS renamed PMOS?

PCOS was renamed because the old term inaccurately emphasized ovarian “cysts” and failed to represent the broader endocrine, metabolic, reproductive and psychological features of the condition.

Does PCOS mean you have ovarian cysts?

No. The ovarian structures historically described as “cysts” in PCOS are actually numerous small follicles rather than pathological ovarian cysts. You also do not need polycystic ovarian morphology to meet adult diagnostic criteria if the other required features are present.

Can you have PMOS without cysts?

Yes. Adults can meet diagnostic criteria for PMOS without polycystic ovarian morphology when ovulatory dysfunction and hyperandrogenism are present and other relevant causes have been excluded.

Is PMOS a different condition from PCOS?

No. PMOS is the new name for the condition previously called PCOS. The 2026 terminology update did not change the current evidence-based diagnostic and management recommendations.

Is PCOS still a correct term?

PCOS remains widely used during the transition to PMOS. Current international resources may use “PMOS,” “formerly PCOS,” or “PMOS/PCOS.” PMOS is expected to become standard terminology with the 2028 International Guideline.

Does having an ovarian cyst mean I have PMOS?

No. Ovarian cysts can occur for many reasons and do not by themselves diagnose PMOS.

Giana's Take

This is why I think this name change is much bigger than semantics.

For decades, the name itself taught women the wrong thing about their bodies.

It made us think cysts = PCOS.

It made a complex endocrine and metabolic condition sound like an ovarian problem.

And it helped center conversations around periods and fertility while other aspects of women's long-term health could be overlooked.

As a biomedical engineer, I care deeply about accurate language because the words we use influence the questions we ask.

And if we're asking the wrong question, we can miss the bigger system.

So yes, you'll still hear me say PCOS while women, clinicians and search engines transition to the new terminology.

But you'll also hear me talking a lot more about PMOS.

Because polyendocrine metabolic ovarian syndrome gives us a much better starting point for understanding what this condition actually is:

Not a cyst problem. Not just a period problem. Not just a fertility problem.

A complex condition that deserves complex, thoughtful, whole-person care.

Sources

The terminology update and transition guidance come from the International Evidence-Based Guideline led by the Monash Centre for Health Research and Implementation. The American Society for Reproductive Medicine has endorsed the transition from PCOS to PMOS. The new terminology resulted from a 14-year global consensus process involving people with lived experience, healthcare professionals, researchers and patient organizations.